COYA vs LH · rev $7.9M vs P/E 23, rev $13.95B
Coya Therapeutics, Inc. Common Stock (COYA) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
COYA currently screens at market cap $118.0M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the COYA and LH stock pages for the full models.
Not investment advice.